AU2016250096A1 - Method and system for microbiome-derived characterization, diagnostics and therapeutics for conditions associated with functional features - Google Patents

Method and system for microbiome-derived characterization, diagnostics and therapeutics for conditions associated with functional features Download PDF

Info

Publication number
AU2016250096A1
AU2016250096A1 AU2016250096A AU2016250096A AU2016250096A1 AU 2016250096 A1 AU2016250096 A1 AU 2016250096A1 AU 2016250096 A AU2016250096 A AU 2016250096A AU 2016250096 A AU2016250096 A AU 2016250096A AU 2016250096 A1 AU2016250096 A1 AU 2016250096A1
Authority
AU
Australia
Prior art keywords
subject
features
condition
diagnosing
microbiome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2016250096A
Other languages
English (en)
Other versions
AU2016250096A8 (en
Inventor
Daniel Almonacid
Zachary APTE
Siavosh Rezvan Behbahani
Jessica RICHMAN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Psomagen Inc
Original Assignee
uBiome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by uBiome Inc filed Critical uBiome Inc
Publication of AU2016250096A1 publication Critical patent/AU2016250096A1/en
Publication of AU2016250096A8 publication Critical patent/AU2016250096A8/en
Assigned to PSOMAGEN, INC. reassignment PSOMAGEN, INC. Request for Assignment Assignors: uBiome, Inc.
Priority to AU2022203347A priority Critical patent/AU2022203347A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Data Mining & Analysis (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biophysics (AREA)
  • Evolutionary Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Databases & Information Systems (AREA)
  • Analytical Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Evolutionary Computation (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Bioethics (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Artificial Intelligence (AREA)
  • Software Systems (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Primary Health Care (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2016250096A 2015-04-13 2016-04-13 Method and system for microbiome-derived characterization, diagnostics and therapeutics for conditions associated with functional features Abandoned AU2016250096A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2022203347A AU2022203347A1 (en) 2015-04-13 2022-05-18 Method and system for microbiome-derived characterization, diaganostics and therapeutics for conditions associated with functional features

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201562146818P 2015-04-13 2015-04-13
US62/146,818 2015-04-13
US201562147096P 2015-04-14 2015-04-14
US201562147334P 2015-04-14 2015-04-14
US62/147,096 2015-04-14
US62/147,334 2015-04-14
PCT/US2016/027349 WO2016168344A1 (en) 2015-04-13 2016-04-13 Method and system for microbiome-derived characterization, diaganostics and therapeutics for conditions associated with functional features

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2022203347A Division AU2022203347A1 (en) 2015-04-13 2022-05-18 Method and system for microbiome-derived characterization, diaganostics and therapeutics for conditions associated with functional features

Publications (2)

Publication Number Publication Date
AU2016250096A1 true AU2016250096A1 (en) 2017-11-09
AU2016250096A8 AU2016250096A8 (en) 2018-12-06

Family

ID=57126060

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2016250096A Abandoned AU2016250096A1 (en) 2015-04-13 2016-04-13 Method and system for microbiome-derived characterization, diagnostics and therapeutics for conditions associated with functional features
AU2022203347A Pending AU2022203347A1 (en) 2015-04-13 2022-05-18 Method and system for microbiome-derived characterization, diaganostics and therapeutics for conditions associated with functional features

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2022203347A Pending AU2022203347A1 (en) 2015-04-13 2022-05-18 Method and system for microbiome-derived characterization, diaganostics and therapeutics for conditions associated with functional features

Country Status (4)

Country Link
EP (1) EP3283650A4 (zh)
CN (1) CN107849616B (zh)
AU (2) AU2016250096A1 (zh)
WO (1) WO2016168344A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3687375A4 (en) * 2016-11-21 2022-01-19 Psomagen, Inc. METHOD AND SYSTEM FOR CHARACTERIZING A HEADACHE RELATED CONDITION
WO2018112419A1 (en) * 2016-12-15 2018-06-21 uBiome, Inc. Method and system for characterizing diet-related conditions
WO2018112437A1 (en) * 2016-12-15 2018-06-21 uBiome, Inc. Method and system for characterizing allergy-related conditions associated with microorganisms
WO2018112459A1 (en) * 2016-12-16 2018-06-21 uBiome, Inc. Method and system for characterizing microorganism-related conditions
KR20210018823A (ko) * 2018-06-07 2021-02-18 4디 파마 피엘씨 Ibs 환자 계층화 방법
US20220189584A1 (en) * 2019-03-29 2022-06-16 Psomagen Inc. Microbiome Byproducts and Uses Thereof
CN115691813A (zh) * 2022-12-30 2023-02-03 神州医疗科技股份有限公司 基于基因组学和微生物组学的遗传性胃癌评估方法及系统

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006097949A1 (en) * 2005-03-16 2006-09-21 Actial Farmacêutica, Lda. Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough
JP2009514551A (ja) * 2005-11-09 2009-04-09 プリメーラ バイオシステムズ インコーポレーティッド 病原体の多重定量検出方法
WO2012050513A1 (en) * 2010-10-11 2012-04-19 Baeckhed Fredrik Method for identifying a risk of cardiovascular disease by analysing oral microbiota
AU2012249322B2 (en) * 2011-04-28 2018-01-04 Sloan-Kettering Institute For Cancer Research HSP90 combination therapy
US20130121968A1 (en) * 2011-10-03 2013-05-16 Atossa Genetics, Inc. Methods of combining metagenome and the metatranscriptome in multiplex profiles
US20140341853A1 (en) * 2013-05-14 2014-11-20 Vanna Hovanky Bacteria-Mediated Therapy for Cancer
CN105407728A (zh) * 2013-07-21 2016-03-16 霍勒拜欧姆公司 用于微生物组表征、监测和治疗的方法和系统

Also Published As

Publication number Publication date
AU2022203347A1 (en) 2022-06-09
EP3283650A4 (en) 2019-04-10
CN107849616B (zh) 2022-03-29
WO2016168344A8 (en) 2018-07-26
EP3283650A1 (en) 2018-02-21
AU2016250096A8 (en) 2018-12-06
WO2016168344A1 (en) 2016-10-20
CN107849616A (zh) 2018-03-27

Similar Documents

Publication Publication Date Title
US10327642B2 (en) Method and system for microbiome-derived characterization, diagnostics and therapeutics for conditions associated with functional features
US10787714B2 (en) Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome functional features
US10786195B2 (en) Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with mircrobiome taxonomic features
US10340045B2 (en) Method and system for microbiome-derived diagnostics and therapeutics for autoimmune system conditions
AU2016250104B2 (en) Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome functional features
AU2022200245A1 (en) Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome taxonomic features
AU2022203347A1 (en) Method and system for microbiome-derived characterization, diaganostics and therapeutics for conditions associated with functional features
AU2016250100A1 (en) Method and system for microbiome-derived characterization, diagnostics and therapeutics for cutaneous conditions
US10311973B2 (en) Method and system for microbiome-derived diagnostics and therapeutics for autoimmune system conditions
AU2016248063A1 (en) Method and system for microbiome-derived diagnostics and therapeutics for autoimmune system conditions

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 31 , NO 44 , PAGE(S) 6450 UNDER THE HEADING PCT APPLICATIONS THAT HAVE ENTERED THE NATIONAL PHASE - NAME INDEX UNDER THE NAME UBIOME, INC., APPLICATION NO. 2016250096, UNDER INID (54) CORRECT THE TITLE TO READ METHOD AND SYSTEM FOR MICROBIOME-DERIVED CHARACTERIZATION, DIAGNOSTICS AND THERAPEUTICS FOR CONDITIONS ASSOCIATED WITH FUNCTIONAL FEATURES

PC1 Assignment before grant (sect. 113)

Owner name: PSOMAGEN, INC.

Free format text: FORMER APPLICANT(S): UBIOME, INC.

MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted